Literature DB >> 15611664

Phosphorylation of Plk1 at S137 and T210 is inhibited in response to DNA damage.

Lyuben Tsvetkov1, David F Stern.   

Abstract

Polo-like kinase 1 (Plk1) regulates multiple processes during mitosis. Plk1 is activated by phosphorylation at the G2/M phase boundary. Active Plk1 is involved in promotion of mitotic entry through activation of Cdc25C, and through nuclear import of cyclin B1 that together activate Cdc2/cyclin B kinase. In earlier work, phosphopeptide mapping identified several phosphorylation sites in Plk1. Mutational analysis pinpointed threonine 210, which is located in the activation loop of the kinase domain, as the major activation site of Plk1. In response to DNA damage, ATM/ATR-dependent checkpoint pathways inhibit Plk1 activity. Insensitivity of Plk1T210D, a constitutively active mutant, to DNA damage-induced inhibition of Plk1 indicates that regulation of Plk1 phosphorylation is a potential target of DNA damage checkpoints. In the present paper, we report that in vivo phosphorylation of Plk1 at serine 137 (S137) and threonine 210 (T210) occurs in mitosis. DNA damage prevents phosphorylation of Plk1 at both S137 and T210 in asynchronous cells but not in mitotic cells. Inhibitors of ATM/ATR and Chk1/Chk2 protein kinases avert the inhibition of Plk1 phosphorylation in response to DNA damage. These data suggest a participation of DNA damage checkpoints in regulation of the signaling pathways upstream of Plk1.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15611664     DOI: 10.4161/cc.4.1.1348

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  32 in total

1.  Centrosomal Chk2 in DNA damage responses and cell cycle progression.

Authors:  Amnon Golan; Elah Pick; Lyuben Tsvetkov; Yasmine Nadler; Harriet Kluger; David F Stern
Journal:  Cell Cycle       Date:  2010-07-01       Impact factor: 4.534

2.  Global phosphoproteome profiling reveals unanticipated networks responsive to cisplatin treatment of embryonic stem cells.

Authors:  Alex Pines; Christian D Kelstrup; Mischa G Vrouwe; Jordi C Puigvert; Dimitris Typas; Branislav Misovic; Anton de Groot; Louise von Stechow; Bob van de Water; Erik H J Danen; Harry Vrieling; Leon H F Mullenders; Jesper V Olsen
Journal:  Mol Cell Biol       Date:  2011-10-17       Impact factor: 4.272

Review 3.  Repair of topoisomerase I-mediated DNA damage.

Authors:  Yves Pommier; Juana M Barcelo; V Ashutosh Rao; Olivier Sordet; Andrew G Jobson; Laurent Thibaut; Ze-Hong Miao; Jennifer A Seiler; Hongliang Zhang; Christophe Marchand; Keli Agama; John L Nitiss; Christophe Redon
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2006

4.  A genetic screen identifies BRCA2 and PALB2 as key regulators of G2 checkpoint maintenance.

Authors:  Tobias Menzel; Viola Nähse-Kumpf; Arne Nedergaard Kousholt; Ditte Kjærsgaard Klein; Christin Lund-Andersen; Michael Lees; Jens Vilstrup Johansen; Randi G Syljuåsen; Claus Storgaard Sørensen
Journal:  EMBO Rep       Date:  2011-07-01       Impact factor: 8.807

5.  The Global Phosphorylation Landscape of SARS-CoV-2 Infection.

Authors:  Mehdi Bouhaddou; Danish Memon; Bjoern Meyer; Kris M White; Veronica V Rezelj; Miguel Correa Marrero; Benjamin J Polacco; James E Melnyk; Svenja Ulferts; Robyn M Kaake; Jyoti Batra; Alicia L Richards; Erica Stevenson; David E Gordon; Ajda Rojc; Kirsten Obernier; Jacqueline M Fabius; Margaret Soucheray; Lisa Miorin; Elena Moreno; Cassandra Koh; Quang Dinh Tran; Alexandra Hardy; Rémy Robinot; Thomas Vallet; Benjamin E Nilsson-Payant; Claudia Hernandez-Armenta; Alistair Dunham; Sebastian Weigang; Julian Knerr; Maya Modak; Diego Quintero; Yuan Zhou; Aurelien Dugourd; Alberto Valdeolivas; Trupti Patil; Qiongyu Li; Ruth Hüttenhain; Merve Cakir; Monita Muralidharan; Minkyu Kim; Gwendolyn Jang; Beril Tutuncuoglu; Joseph Hiatt; Jeffrey Z Guo; Jiewei Xu; Sophia Bouhaddou; Christopher J P Mathy; Anna Gaulton; Emma J Manners; Eloy Félix; Ying Shi; Marisa Goff; Jean K Lim; Timothy McBride; Michael C O'Neal; Yiming Cai; Jason C J Chang; David J Broadhurst; Saker Klippsten; Emmie De Wit; Andrew R Leach; Tanja Kortemme; Brian Shoichet; Melanie Ott; Julio Saez-Rodriguez; Benjamin R tenOever; R Dyche Mullins; Elizabeth R Fischer; Georg Kochs; Robert Grosse; Adolfo García-Sastre; Marco Vignuzzi; Jeffery R Johnson; Kevan M Shokat; Danielle L Swaney; Pedro Beltrao; Nevan J Krogan
Journal:  Cell       Date:  2020-06-28       Impact factor: 41.582

6.  Regulation of polo-like kinase 1 by DNA damage and PP2A/B55α.

Authors:  Ling Wang; Qingyuan Guo; Laura A Fisher; Dongxu Liu; Aimin Peng
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

7.  Regulation of I(kappa)B kinase complex by phosphorylation of (gamma)-binding domain of I(kappa)B kinase (beta) by Polo-like kinase 1.

Authors:  Tomoyasu Higashimoto; Nymph Chan; Yung-Kang Lee; Ebrahim Zandi
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

8.  Polo-like kinase 1 enhances survival and mutagenesis after genotoxic stress in normal cells through cell cycle checkpoint bypass.

Authors:  Gina Chun; Dongsoon Bae; Kristen Nickens; Travis J O'Brien; Steven R Patierno; Susan Ceryak
Journal:  Carcinogenesis       Date:  2010-01-20       Impact factor: 4.944

9.  Reduced kinase activity of polo kinase Cdc5 affects chromosome stability and DNA damage response in S. cerevisiae.

Authors:  Chetan C Rawal; Sara Riccardo; Chiara Pesenti; Matteo Ferrari; Federica Marini; Achille Pellicioli
Journal:  Cell Cycle       Date:  2016-08-26       Impact factor: 4.534

10.  Elevated levels of the polo kinase Cdc5 override the Mec1/ATR checkpoint in budding yeast by acting at different steps of the signaling pathway.

Authors:  Roberto Antonio Donnianni; Matteo Ferrari; Federico Lazzaro; Michela Clerici; Benjamin Tamilselvan Nachimuthu; Paolo Plevani; Marco Muzi-Falconi; Achille Pellicioli
Journal:  PLoS Genet       Date:  2010-01-22       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.